A case of CDKL5 disorder: Improved ADL by simple treatment strategy for intractable epileptic seizures

Tatsuhiko Shike, Yukitoshi Takahashi, Nobusuke Kimura, Katsumi Imai, Toshiyuki Yamamoto, Takao Takahashi

Research output: Contribution to journalArticle

Abstract

CDKL5 gene mutations are the cause of symptomatic infantile epilepsy in some patients. Such patients present with partial seizures and characteristic hand movements that are often observed in patients with Rett syndrome. This clinical entity has recently been recognized as CDKL5 disorder. In a girl with CDKL5 disorder, who had been treated with combinatory therapy using many anti-epileptic drugs, we were able to control the seizures with valproate monotherapy. As a result of the monotherapy, the patient's seizures ameliorated temporarily and her quality of life improved. Some patients show improvement in seizures during the natural course of CDKL5 disorder. Therefore, there is a possibility that this was also the case in our patient. However, the patient and her family were satisfied with the improvement in quality of life after the withdrawal of the multi-drug combinatory therapy. Thus, it is important to select the best therapy for patients with intractable epilepsy through long term follow-up.

Original languageEnglish
Pages (from-to)28-31
Number of pages4
JournalNo To Hattatsu
Volume49
Issue number1
Publication statusPublished - 2017

Fingerprint

Activities of Daily Living
Epilepsy
Seizures
Therapeutics
Quality of Life
Rett Syndrome
Valproic Acid
Hand
Drug Therapy
Mutation
Pharmaceutical Preparations
Genes

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Medicine(all)
  • Clinical Neurology

Cite this

A case of CDKL5 disorder : Improved ADL by simple treatment strategy for intractable epileptic seizures. / Shike, Tatsuhiko; Takahashi, Yukitoshi; Kimura, Nobusuke; Imai, Katsumi; Yamamoto, Toshiyuki; Takahashi, Takao.

In: No To Hattatsu, Vol. 49, No. 1, 2017, p. 28-31.

Research output: Contribution to journalArticle

Shike, T, Takahashi, Y, Kimura, N, Imai, K, Yamamoto, T & Takahashi, T 2017, 'A case of CDKL5 disorder: Improved ADL by simple treatment strategy for intractable epileptic seizures', No To Hattatsu, vol. 49, no. 1, pp. 28-31.
Shike, Tatsuhiko ; Takahashi, Yukitoshi ; Kimura, Nobusuke ; Imai, Katsumi ; Yamamoto, Toshiyuki ; Takahashi, Takao. / A case of CDKL5 disorder : Improved ADL by simple treatment strategy for intractable epileptic seizures. In: No To Hattatsu. 2017 ; Vol. 49, No. 1. pp. 28-31.
@article{2bfa0a6a6a404435bb5230a54859d793,
title = "A case of CDKL5 disorder: Improved ADL by simple treatment strategy for intractable epileptic seizures",
abstract = "CDKL5 gene mutations are the cause of symptomatic infantile epilepsy in some patients. Such patients present with partial seizures and characteristic hand movements that are often observed in patients with Rett syndrome. This clinical entity has recently been recognized as CDKL5 disorder. In a girl with CDKL5 disorder, who had been treated with combinatory therapy using many anti-epileptic drugs, we were able to control the seizures with valproate monotherapy. As a result of the monotherapy, the patient's seizures ameliorated temporarily and her quality of life improved. Some patients show improvement in seizures during the natural course of CDKL5 disorder. Therefore, there is a possibility that this was also the case in our patient. However, the patient and her family were satisfied with the improvement in quality of life after the withdrawal of the multi-drug combinatory therapy. Thus, it is important to select the best therapy for patients with intractable epilepsy through long term follow-up.",
author = "Tatsuhiko Shike and Yukitoshi Takahashi and Nobusuke Kimura and Katsumi Imai and Toshiyuki Yamamoto and Takao Takahashi",
year = "2017",
language = "English",
volume = "49",
pages = "28--31",
journal = "No To Hattatsu",
issn = "0029-0831",
publisher = "Japanese Society of Child Neurology",
number = "1",

}

TY - JOUR

T1 - A case of CDKL5 disorder

T2 - Improved ADL by simple treatment strategy for intractable epileptic seizures

AU - Shike, Tatsuhiko

AU - Takahashi, Yukitoshi

AU - Kimura, Nobusuke

AU - Imai, Katsumi

AU - Yamamoto, Toshiyuki

AU - Takahashi, Takao

PY - 2017

Y1 - 2017

N2 - CDKL5 gene mutations are the cause of symptomatic infantile epilepsy in some patients. Such patients present with partial seizures and characteristic hand movements that are often observed in patients with Rett syndrome. This clinical entity has recently been recognized as CDKL5 disorder. In a girl with CDKL5 disorder, who had been treated with combinatory therapy using many anti-epileptic drugs, we were able to control the seizures with valproate monotherapy. As a result of the monotherapy, the patient's seizures ameliorated temporarily and her quality of life improved. Some patients show improvement in seizures during the natural course of CDKL5 disorder. Therefore, there is a possibility that this was also the case in our patient. However, the patient and her family were satisfied with the improvement in quality of life after the withdrawal of the multi-drug combinatory therapy. Thus, it is important to select the best therapy for patients with intractable epilepsy through long term follow-up.

AB - CDKL5 gene mutations are the cause of symptomatic infantile epilepsy in some patients. Such patients present with partial seizures and characteristic hand movements that are often observed in patients with Rett syndrome. This clinical entity has recently been recognized as CDKL5 disorder. In a girl with CDKL5 disorder, who had been treated with combinatory therapy using many anti-epileptic drugs, we were able to control the seizures with valproate monotherapy. As a result of the monotherapy, the patient's seizures ameliorated temporarily and her quality of life improved. Some patients show improvement in seizures during the natural course of CDKL5 disorder. Therefore, there is a possibility that this was also the case in our patient. However, the patient and her family were satisfied with the improvement in quality of life after the withdrawal of the multi-drug combinatory therapy. Thus, it is important to select the best therapy for patients with intractable epilepsy through long term follow-up.

UR - http://www.scopus.com/inward/record.url?scp=85018280772&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85018280772&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:85018280772

VL - 49

SP - 28

EP - 31

JO - No To Hattatsu

JF - No To Hattatsu

SN - 0029-0831

IS - 1

ER -